WELL Health Technologies Corp.

WELL.TOTSXHealthcare● Active

$4.84

$-0.21(-4.16%)

Market Cap$1.2B

P/E Ratio—

52W High$6.08

52W Low$3.58

Avg Volume1.6M

Open$5.00

Beta1.33

Free Cash Flow Financials Revenue

WELL Health Technologies Corp. (WELL.TO) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

WELL.TO · free cash flow · updated Jun 8, 2026

Core FCF metrics

WELL.TO · FCF · TTM · margin & CAGR

Free cash flow was $87.9M for FY2025 (fiscal year ending 2025-12-31), up 1411.4% year-over-year The FCF margin was 6.3%.

FY2025 Free Cash Flow$87.9M▲ +1411.4% YoY

Trailing 12M (TTM)$79.4Mtrailing 4 quarters sum

FCF Margin6.3%$87.9M ÷ revenue

3-Year CAGR+7.8%FY2022 → FY2025

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

WELL.TO · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$115.8M(28M)$87.9M▲ +1411.4%6.3%

FY2024$9.5M(16M)−$6.7M▼ 118.0%-0.7%

FY2023$66.4M(25M)$37.2M▼ 47.0%4.8%

FY2022$76.5M(6M)$70.1M▲ +258.1%12.3%

FY2021$22.3M(3M)$19.6M▲ +400.5%6.5%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

WELL.TO · P/FCF · FCF yield · FCF per share

WELL Health Technologies Corp. (WELL.TO) trades at a FCF yield of 6.43% and a price-to-free-cash-flow ratio of 96.8x. FCF per share stands at $0.05, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

6.43%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$0.05

TTM FCF ÷ Shares Outstanding

Price / FCF

x96.8

Share Price ÷ FCF per Share

EV / FCF (TTM)

x23.8

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

WELL.TO · cash flow statement · operating / investing / financing

For FY2025, WELL Health Technologies Corp. generated $115.8M in operating cash flow and spent 28M in capital expenditures, yielding $87.9M in free cash flow.

Operating Activities

+$115.8M

Cash from core business operations

2025-12-31

Investing Activities

−$111.7M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$0.9M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($115.8M) − |CapEx| (28M) = FCF ($87.9M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

WELL.TO vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

WELL Health Technologies Corp.YOU

WELL.TO

$87.9M+1411.4%6.3%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

WELL Health Technologies Corp. (WELL.TO) reported free cash flow of $87.9M for FY2025 (fiscal year ending 2025-12-31), up 1411.4% year-over-year. The FCF margin was 6.3%.

Based on available data, WELL Health Technologies Corp. has maintained positive free cash flow for at least 4 fiscal year(s). FCF peaked at $87.9M in FY2025.

WELL Health Technologies Corp.'s FCF yield is 6.43% and price-to-FCF ratio is 96.8x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

WELL.TO free cash flow · 8 questions

WELL Health Technologies Corp. free cash flow was $87.9M for FY2025, up 1411.4% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $79.4M.

WELL.TO free cash flowWELL.TO FCFWELL.TO FCF 2025WELL.TO free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · WELL Health Technologies Corp. · WELL Health Technologies Corp. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026